340B 2023
Functionality & Pricing Drive Purchase Decisions
Purchasing energy in the 340B market has been high in recent years as (1) healthcare organizations have sought to increase savings, particularly in cost centers like pharmacies, and (2) 340B vendors have expanded the types of customers they serve. This report examines 49 recent purchase decisions validated by KLAS between October 2020 and October 2022 to understand why certain vendors are seeing the most purchase energy and who is being replaced. When available, satisfaction data from current customers is also included.
If you don't have a login, getting started is easy.
Key Findings:
- PharmaForce Highly Considered and Selected Thanks to Functionality and Rapport during Sales Process
- Large Organizations Look to Verity Solutions Due to Consistency and System Capabilities
- Sentry Data Systems and Macro Helix Most Frequently Being Replaced; Customers Cite Functionality, Relationship, and Pricing
- Declining Data Quality Prompts Customers of RxStrategies and CaptureRx to Consider Other Options
- Vendor Summaries
Writer
Sarah Hanson
Designer
Jessica Bonnett
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.